did fda ban semaglutide on Compounded GLP-1 Drugs: What to Know What Patients Need to Know

3 Literature search methodology The primary goal of this review was to provide a detailed overview of nutrients beneficial for DED management and to assess potential health risks associated with their use

Our progress in understanding the molecular mechanisms governing eryptosis allowed shedding light on signaling pathways mediating the development of morphological alterations associated with eryptosis

Additionally, further investigation is needed through prospective studies confirming comparative safety, examining clinical outcomes related to GI events, and performing head-to-head comparisons of GLP-1 RAs

10.1186/s12902-023-01497-x BMC Endocr Disord